These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27822139)

  • 21. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
    Rico C; Boerboom D; Paquet M
    Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retraction Note: Thyroid nodules update in diagnosis and management.
    Tamhane S; Gharib H
    Clin Diabetes Endocrinol; 2016; 2():10. PubMed ID: 28707682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours.
    Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V
    Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of a new histological and molecular-based classification of canine mammary neoplasia.
    Im KS; Kim NH; Lim HY; Kim HW; Shin JI; Sur JH
    Vet Pathol; 2014 May; 51(3):549-59. PubMed ID: 24003019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Of humans and canines: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours.
    Kumaraguruparan R; Prathiba D; Nagini S
    Res Vet Sci; 2006 Oct; 81(2):218-24. PubMed ID: 16740286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retraction note: Uterine mast cell tumor: a clinical and cytohistopathological study.
    Bahrami AM; Khaki F; Zehtabian S; Cheraghi J; Rashnavadi M; Ahmadi MR; Naderafif M; Javaherypour S; Mohsenzadeh S; Hosseini E; Masoudi H; Pourzaer M
    J Ovarian Res; 2016 Nov; 9(1):77. PubMed ID: 27814770
    [No Abstract]   [Full Text] [Related]  

  • 27. Retraction Note: Coronavirus herd immunity optimizer to solve classification problems.
    Alweshah M
    Soft comput; 2023; 27(13):9219. PubMed ID: 37255916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
    Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
    Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single Nucleotide Polymorphisms Influence Histological Type and Grade of Canine Malignant Mammary Tumours.
    Canadas-Sousa A; Santos M; Medeiros R; Dias-Pereira P
    J Comp Pathol; 2019 Oct; 172():72-79. PubMed ID: 31690419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
    Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
    BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
    Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
    Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables.
    Matos AJ; Lopes C; Carvalheira J; Santos M; Rutteman GR; Gärtner F
    J Comp Pathol; 2006; 134(2-3):182-9. PubMed ID: 16545841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retraction Note to: Mutation pattern is an influential factor on functional mutation rates in cancer.
    Du C; Wu X; Li J
    Cancer Cell Int; 2017; 17():67. PubMed ID: 28690427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retraction Note to: Accurate computation: COVID-19 rRT-PCR positive test dataset using stages classification through textual big data mining with machine learning.
    Ramanathan S; Ramasundaram M
    J Supercomput; 2023; 79(6):7065. PubMed ID: 36466776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrosine kinase expression analyses in canine mammary gland tumours - A pilot study.
    Koltai Z; Szabó B; Jakus J; Vajdovich P
    Acta Vet Hung; 2018 Jun; 66(2):294-308. PubMed ID: 29958529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytological Grading of Breast Tumors-The Human and Canine Perspective.
    Kuppusamy K; Rajan A; Warrier A; Nadhan R; Patra D; Srinivas P
    Front Vet Sci; 2019; 6():283. PubMed ID: 31508437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer.
    Gray M; Meehan J; Martínez-Pérez C; Kay C; Turnbull AK; Morrison LR; Pang LY; Argyle D
    Front Oncol; 2020; 10():617. PubMed ID: 32411603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retraction Note to: Nicorandil accelerates recovery of neuromuscular block caused by vecuronium.
    Can J Anaesth; 2015 Aug; 62(8):942. PubMed ID: 26108533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
    Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
    Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the glutamine metabolism-related proteins glutaminase 1 and glutamate dehydrogenase in canine mammary tumours.
    Ryu JE; Park HK; Choi HJ; Lee HB; Lee HJ; Lee H; Yu ES; Son WC
    Vet Comp Oncol; 2018 Jun; 16(2):239-245. PubMed ID: 29266697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.